Repligen | Ativos



Assets Alterar Data
Agilent USD 12.16B 244M 2025-04
Align Technology USD 6.22B 116.27M 2025-06
Bio Techne USD 2.56B 86.39M 2025-06
BioMarin Pharmaceutical USD 7.46B 309.33M 2025-06
Bristol-Myers Squibb USD 94.68B 2.25B 2025-06
Bruker USD 6.34B 406.7M 2025-06
Charles River Laboratories USD 7.56B 21.82M 2025-06
Danaher USD 81.62B 2.5B 2025-06
Dentsply International USD 6.07B 19M 2025-06
Exact Sciences USD 5.8B 86.29M 2025-06
General Electric Aerospace USD 125.26B 1.13B 2025-06
Henry Schein USD 10.91B 426M 2025-06
Illumina USD 6.09B 95M 2025-06
IQVIA Holdings USD 28.63B 1.31B 2025-06
Mettler Toledo International USD 3.4B 165.79M 2025-06
Myriad Genetics USD 1.01B 21.5M 2025-03
Pfizer USD 206.1B 1.93B 2025-06
Repligen USD 2.85B 22.48M 2025-03
Revvity USD 12.36B 2.06M 2025-06
Standard Biotools USD 612.34M 69.19M 2024-12
Thermo Fisher Scientific USD 101.23B 2.19B 2025-06
Waters USD 4.72B 126.5M 2025-06
West Pharmaceutical Services USD 3.95B 334.6M 2025-06


Repligen Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.